PMID- 26556105 OWN - NLM STAT- MEDLINE DCOM- 20160914 LR - 20151130 IS - 1096-0023 (Electronic) IS - 1043-4666 (Linking) VI - 77 DP - 2016 Jan TI - Majoon ushba, a polyherbal compound ameliorates rheumatoid arthritis via regulating inflammatory and bone remodeling markers in rats. PG - 115-26 LID - S1043-4666(15)30090-9 [pii] LID - 10.1016/j.cyto.2015.11.002 [doi] AB - The present study was aimed to investigate the anti-arthritic effect of majoon ushba (MU) and its underlying mechanism in adjuvant induced arthritis (AIA) rats. Arthritis was induced by intradermal injection of complete freund's adjuvant (0.1ml) into the right hind paw of the Wistar albino rats. MU (1000mg/kg/b.wt) and methotrexate (3mg/kg/b.wt) were administered from day 11 to day 18th for 8days after adjuvant induction. We have found that MU treatment significantly increased the level of anti-inflammatory cytokine (IL-10) and inhibited the over production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6) and monocyte chemoattractant protein-1 (MCP-1) (ELISA) in the serum of adjuvant-induced arthritic rats. The mRNA expression of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6, and IL-17), inflammatory enzymes (inducible nitric oxide synthase (iNOS) and cyclo-oxygenase-2 (COX-2)), MCP-1, receptor activator of nuclear factor-kB ligand (RANKL) and transcription factors (NF-small ka, CyrillicB and AP-1) (Real-Time PCR) was found significantly downregulated in the synovial tissues of MU treated arthritic rats. In addition, the protein expression of NF-small ka, CyrillicB, IL-17, COX-2, and RANKL (western blotting and immunohistochemistry analysis) was found reduced. On the other hand, osteoprotegerin (OPG), a bone remodeling marker was found to be elevated in synovial tissues of MU treated arthritic rats. Furthermore, MU treatment prevented body weight loss and reduced the joint paw edema, cell infiltration, cartilage and bone degradation as evidenced by the histopathological and radiological analysis. In conclusion, our current findings provide scientific evidence for the traditional claim of MU as an anti-arthritic drug. CI - Copyright (c) 2015 Elsevier Ltd. All rights reserved. FAU - Ganesan, Ramamoorthi AU - Ganesan R AD - Immunopathology Lab, School of Bio Sciences and Technology, VIT University, Vellore 632 014, Tamil Nadu, India. FAU - Doss, Hari Madhuri AU - Doss HM AD - Immunopathology Lab, School of Bio Sciences and Technology, VIT University, Vellore 632 014, Tamil Nadu, India. FAU - Rasool, Mahaboobkhan AU - Rasool M AD - Immunopathology Lab, School of Bio Sciences and Technology, VIT University, Vellore 632 014, Tamil Nadu, India. Electronic address: mkr474@gmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151108 PL - England TA - Cytokine JT - Cytokine JID - 9005353 RN - 0 (Biomarkers) RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 0 (NF-kappa B) RN - 0 (Plant Preparations) RN - 0 (majoon ushba) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.14.99.1 (Cyclooxygenase 2) SB - IM MH - Animals MH - Arthritis, Experimental/genetics/metabolism/*prevention & control MH - Arthritis, Rheumatoid/genetics/metabolism/*prevention & control MH - Biomarkers/blood/*metabolism MH - Blotting, Western MH - Bone Remodeling/*drug effects MH - Chemokine CCL2/genetics/metabolism MH - Cyclooxygenase 2/genetics/metabolism MH - Cytokines/blood/genetics/metabolism MH - Edema/prevention & control MH - Female MH - Gene Expression/drug effects MH - Hindlimb/drug effects/metabolism/pathology MH - Immunohistochemistry MH - Inflammation Mediators/blood/*metabolism MH - Male MH - NF-kappa B/genetics/metabolism MH - Nitric Oxide Synthase Type II/genetics/metabolism MH - Phytotherapy/methods MH - Plant Preparations/*pharmacology MH - Plants, Medicinal/chemistry MH - Rats, Wistar MH - Reverse Transcriptase Polymerase Chain Reaction OTO - NOTNLM OT - Inflammatory enzymes OT - Majoon ushba OT - Pro-inflammatory cytokines OT - Rheumatoid arthritis EDAT- 2015/11/12 06:00 MHDA- 2016/09/15 06:00 CRDT- 2015/11/12 06:00 PHST- 2015/07/03 00:00 [received] PHST- 2015/10/20 00:00 [revised] PHST- 2015/11/02 00:00 [accepted] PHST- 2015/11/12 06:00 [entrez] PHST- 2015/11/12 06:00 [pubmed] PHST- 2016/09/15 06:00 [medline] AID - S1043-4666(15)30090-9 [pii] AID - 10.1016/j.cyto.2015.11.002 [doi] PST - ppublish SO - Cytokine. 2016 Jan;77:115-26. doi: 10.1016/j.cyto.2015.11.002. Epub 2015 Nov 8.